Montelukast sodium and Lipids abnormal - a phase IV clinical study of FDA data
Summary:
Lipids abnormal is reported as a side effect among people who take Montelukast sodium (montelukast sodium), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Albuterol, and have Wheezing.
The phase IV clinical study analyzes which people have Lipids abnormal when taking Montelukast sodium. It is created by eHealthMe based on reports of 24,779 people who have side effects when taking Montelukast sodium from the FDA, and is updated regularly.
What is Montelukast sodium?
Montelukast sodium has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 26,093 Montelukast sodium users. Check the latest studies of Montelukast sodium.
What is Lipids abnormal?
Lipids abnormal is found to be associated with 1,245 drugs and 463 conditions by eHealthMe. Check the latest studies of Lipids abnormal.
24,779 people reported to have side effects when taking Montelukast sodium.
Among them, 121 people (0.49%) have Lipids abnormal.
Among these 121 people:
How long have people been on Montelukast sodium when they have Lipids abnormal? *
What is the gender of people who have Lipids abnormal when taking Montelukast sodium? *
What is the age of people who have Lipids abnormal when taking Montelukast sodium? *
What are other drugs people take besides Montelukast sodium? *
What are other side effects people have besides Lipids abnormal? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Montelukast sodium and have Lipids abnormal?
- Check whether Lipids abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Montelukast sodium:
- Montelukast sodium (26,093 reports)
Lipids abnormal treatments and more:
- Lipids abnormal (2,932 reports)
How severe was Lipids abnormal and when was it recovered:
Expand to all the drugs that have ingredients of montelukast sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Montelukast sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Lipids abnormal:
- Lipids abnormal (1,245 drugs)
Browse all the conditions that are associated with Lipids abnormal:
- Lipids abnormal (463 conditions)
Related publications that referenced our studies
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Montelukast sodium) and Montelukast sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Letermovir and Tacrolimus drug interactions for boys aged 10-19 - 4 seconds ago
- Could Imbruvica cause Upper Respiratory Tract Congestion? - 6 seconds ago
- Drug interactions of Ramipril and Rosiglitazone - 12 seconds ago
- Could Cymbalta cause Electrolyte Imbalance? - 13 seconds ago
- Laryngospasm and drugs of ingredients of mirtazapine - 15 seconds ago
- Drug interactions of Vitamin E and Flonase - 20 seconds ago
- Could Chantix cause Furuncle? - 21 seconds ago
- Could Zemplar cause Squamous Cell Carcinoma? - 27 seconds ago
- Azithromycin and Ciprofloxacin drug interactions for girls aged 10-19 - 28 seconds ago
- Pantothenate and Stress And Anxiety for Men aged 40-49 - 29 seconds ago